The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Scientific Advice Meetings for Centrally Registered Products (EMEA)
Posted 01 March 2009 | By
Scientific Advice is the process of seeking guidance from the European Medicines Agency (EMEA) during the drug development phase. Scientific Advice is designed to speed up the development and availability of high-quality, effective and acceptably safe medicines for the benefit of patients.1 The group responsible for giving scientific advice started its work as a consultation group in 1996 and as a formal Committee for Proprietary Medicinal Products (CPMP) working group in 2003.2 The new Regulation (EC) No. 726/2004 (Annex I) established the Scientific Advice Working Party (SAWP) as a standing working party of the Committee for Medicinal Products for Human Use (CHMP), with the sole purpose of providing scientific advice, particularly regarding the development of new therapies.3